By 2021, it will be 40 years since the human immunodeficiency virus (HIV) was identified without breakthrough on vaccine or cure.
But in 10 months, the COVID-19 pandemic has found at least one approved vaccine from a basket of seven selected candidates in phase three of clinical trials and more t
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
